Consequently, we set out to evaluate the effect of 4EBP1 targeting in ER+, 8p11-p12 expressing breast cancer cells as well as other breast cancer cell lines, and non-tumorigenic but immortalized human mammary epithelial cells. This evidence concerns the gene EIF4EBP1 and breast cancer.